Spyre Therap (SYRE)
$18.32
0.38 (2.07%)
SYRE Stock Quote Delayed 30 Minutes
SYRE Stock Earnings: Spyre Therapeutics Beats EPS for Q2 2024
SYRE stock results show that Spyre Therapeutics beat analyst estimates for earnings per share the second quarter of 2024.
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
$19.70
Market Cap
1.08B
PE Ratio
-17.94
EPS
-1.0209
Volume (Avg. Vol.)
525,694
Day's Range
$17.56 - $20.
52-Week Range
$17.56 - $47.97
Dividend & Yield
N/A (N/A)
